AAAAAA

   
Results: 1-8 |
Results: 8
A novel splice-site mutation in intron 7 causes more severe hypercholesterolemia than a combined FH-FDB defect
Authors: deCampo, A Schallmoser, K Schmidt, H Toplak, H Kostner, GM
Citation: A. Decampo et al., A novel splice-site mutation in intron 7 causes more severe hypercholesterolemia than a combined FH-FDB defect, ATHEROSCLER, 157(2), 2001, pp. 524-525
Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease
Authors: Renner, W Koppel, H Brodmann, M Pabst, E Schallmoser, K Toplak, H Wascher, TC Pilger, E
Citation: W. Renner et al., Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease, THROMB HAEM, 83(1), 2000, pp. 20-22
Prothrombin G20210A, factor V Leiden, and factor XIII Va134Leu: Common mutations of blood coagulation factors and deep vein thrombosis in Austria
Authors: Renner, W Koppel, H Hoffmann, C Schallmoser, K Stanger, O Toplak, H Wascher, TC Pilger, E
Citation: W. Renner et al., Prothrombin G20210A, factor V Leiden, and factor XIII Va134Leu: Common mutations of blood coagulation factors and deep vein thrombosis in Austria, THROMB RES, 99(1), 2000, pp. 35-39
C242T polymorphism of the p22 phox gene is not associated with peripheral arterial occlusive disease
Authors: Renner, W Schallmoser, K Gallippi, P Krauss, C Toplak, H Wascher, TC Pilger, E
Citation: W. Renner et al., C242T polymorphism of the p22 phox gene is not associated with peripheral arterial occlusive disease, ATHEROSCLER, 152(1), 2000, pp. 175-179
Evaluation of a newly discovered LDL-receptor-mutation (exon 10, GAC > AAC, D471N, "FH graz-1") in familial hypercholesterolemia - a family study
Authors: de Campo, A Toplak, H Wascher, TC Schallmoser, K Friehs, A Schmidt, H Kostner, GM
Citation: A. De Campo et al., Evaluation of a newly discovered LDL-receptor-mutation (exon 10, GAC > AAC, D471N, "FH graz-1") in familial hypercholesterolemia - a family study, ACT MED AUS, 26(1), 1999, pp. 20-25
Effects of intensified lifestyle modification on the need for further revascularization after coronary angioplasty
Authors: Wallner, S Watzinger, N Lindschinger, M Smolle, KH Toplak, H Eber, B Dittrich, P Elmadfa, I Klein, W Krejs, GJ Wascher, TC
Citation: S. Wallner et al., Effects of intensified lifestyle modification on the need for further revascularization after coronary angioplasty, EUR J CL IN, 29(5), 1999, pp. 372-379
Impact of fat distribution on risk
Authors: Toplak, H
Citation: H. Toplak, Impact of fat distribution on risk, ACT MED AUS, 25(4-5), 1998, pp. 131-132
The reduction of overweight and the improvement of metabolic parameters with the lipase inhibitor Orlistat: Preliminary results
Authors: Toplak, H Marhardt, K
Citation: H. Toplak et K. Marhardt, The reduction of overweight and the improvement of metabolic parameters with the lipase inhibitor Orlistat: Preliminary results, ACT MED AUS, 25(4-5), 1998, pp. 142-145
Risultati: 1-8 |